Academe Learn
CBME Curriculum Preview

Page 25 of 25

PE9.1-7,PE10.1-6,PE11.1-4 | Nutrition Assessment and Support — PBL Case

CLINICAL SETTING

You are a junior resident posted in the paediatric ward of a 200-bed district hospital in Sitapur, Uttar Pradesh. It is a Monday morning and the ward is busy with post-weekend admissions. An ASHA worker has arrived with a mother and her 22-month-old daughter, Kamla, referred from the local Anganwadi centre. The ASHA's referral note reads: 'Child not eating well for 3 months. Swelling of both feet noticed 2 days ago. Weight at AWC is 6.8 kg (last month it was 7.1 kg). Family poor, father is daily-wage labourer. Mother has been ill with TB and is on Category I DOTS.' You are the first clinician to see this child.

Trigger 1: First Contact — History and Vital Signs

You take a history from the mother through the ASHA. Kamla was born at term, birth weight 2.9 kg. She was breastfed for 14 months. Complementary feeding started at 6 months with diluted rice gruel. The current diet consists of rice, dal twice daily, and occasional vegetables. No eggs, meat, or milk in the past 3 months. The mother reports Kamla has had three episodes of diarrhoea in the past 2 months, each lasting 4–5 days. She has not been hospitalised before. Immunisations are up to date per the mother. On initial examination: child is irritable, apathetic. Temperature 36.1°C (axillary), HR 124/min, RR 36/min, SpO2 96% on room air. Weight 6.8 kg, length 80 cm. There is bilateral pitting oedema to the mid-calf. Hair is sparse and discoloured (reddish-brown, flag sign). Skin over the legs shows 'flaky-paint' desquamation. Abdomen: distended with visible flanks.

DISCUSSION POINTS

  • What is your immediate working diagnosis based on the history and initial findings? What specific features support this diagnosis?
  • Kamla's weight is 6.8 kg at 22 months. Using WHO growth charts, what is her approximate weight-for-age Z-score? What is the significance of the weight having decreased from 7.1 kg last month?
  • The mother has active TB on DOTS. How does this affect your assessment of Kamla's nutritional risk? What additional history would you seek?
  • What is the significance of bilateral pitting oedema in a malnourished child even when WHZ is not <−3 SD?
Click to reveal Trigger 2: Full Assessment — Anthropometry and Clinical Examination (discuss previous trigger first!)

Trigger 2: Full Assessment — Anthropometry and Clinical Examination

You complete your assessment. MUAC measures 10.9 cm. Weight-for-height Z-score calculated as −2.8 SD (using WHO 2006 growth reference). Blood glucose on ward glucometer: 2.4 mmol/L (43 mg/dL). Axillary temperature confirms hypothermia at 36.1°C. The child is able to respond to her mother's voice but is listless and has not breastfed in the past 24 hours per the mother. On systematic examination: pallor ++ (conjunctivae), no Bitot's spots, no angular stomatitis, no goitre. No lymphadenopathy. Respiratory examination: vesicular breath sounds, no added sounds. Cardiac: soft systolic murmur at LSE (grade 1/6). Abdomen: tender on palpation, liver span 8 cm, no palpable spleen. CNS: globally hypotonic, no focal deficit. Skin: flaky-paint dermatosis confirmed on both legs and forearms. Buttocks: 'baggy pants' appearance.

DISCUSSION POINTS

  • Classify Kamla's nutritional status precisely using WHO/IAP criteria. Which criterion/criteria define her classification? Is this complicated or uncomplicated SAM? Justify your answer.
  • You have identified hypoglycaemia (blood glucose 2.4 mmol/L) and hypothermia (36.1°C) simultaneously. As per the WHO 10-step SAM protocol, what immediate actions should you take in the FIRST 30 minutes? What is the correct agent, dose, and route for hypoglycaemia treatment?
  • Kamla has a soft systolic murmur. How does this influence your fluid management decision in SAM? Why is IV saline NOT the correct choice for rehydration in SAM?
  • The dietary assessment shows no milk products for 3 months. Which specific micronutrient deficiencies are most likely, and what clinical signs support each?
Click to reveal Trigger 3: Stabilisation Phase — Day 3 (discuss previous trigger first!)

Trigger 3: Stabilisation Phase — Day 3

Day 3 of admission. Kamla has been receiving F-75 formula 105 mL every 3 hours via NGT (nasogastric tube inserted as she was refusing oral feeds on day 1). She has received amoxicillin and gentamicin. The oedema has reduced from mid-calf to only the ankles. Blood glucose now 4.2 mmol/L (76 mg/dL). Temperature 36.8°C. She seems slightly more alert. Her weight today is 6.5 kg (down from 6.8 kg at admission — the team explains to the trainee that this weight loss indicates oedema resolution). The nursing staff ask you: 'Doctor, the oedema is getting better — can we change to F-100 now and try to push her weight up?' The mother is anxious and asks whether Kamla will recover fully and when she can go home. The dietitian has started a diet history and notes the family's income is approximately Rs 4,000/month for four members.

DISCUSSION POINTS

  • Is it appropriate to transition Kamla from F-75 to F-100 now? What specific criteria must be met before transitioning? What are the risks of premature F-100 introduction?
  • The nursing staff interpret weight loss (6.8 → 6.5 kg) as a poor sign. Is this correct? How do you explain oedema-fluid diuresis to the team and the family?
  • Given the family's socioeconomic constraints (Rs 4,000/month, four members), how do you counsel the mother on a realistic diet plan for rehabilitation at home? Which locally available Indian foods can provide the required caloric and protein density without RUTF?
  • What government programme (NRC/NHM) would support this family after discharge? What is the standard post-discharge follow-up schedule under the national SAM management protocol?
Click to reveal Trigger 4: Community Follow-up and Prevention (discuss previous trigger first!)

Trigger 4: Community Follow-up and Prevention

Kamla is discharged on day 18 with WHZ now −2.0 SD, no oedema for 10 days, and she is eating F-100 (transitioned on day 10 when oedema resolved and she passed the appetite test). She is enrolled in the local NRC (Nutrition Rehabilitation Centre) follow-up programme. At the 4-week post-discharge visit, the ASHA reports that a younger sibling (14 months, weight 7.2 kg) also appears underweight. The ASHA asks you to assess the sibling and advise the family on prevention. Separately, the community health officer asks the team to prepare a brief educational session for the local Anganwadi workers on early identification of malnutrition, MUAC screening, and ICDS referral criteria. He also raises a concern: a 12-year-old girl in the same family has been gaining weight rapidly and now appears overweight. He asks whether the family should be worried.

DISCUSSION POINTS

  • Assess the 14-month sibling's nutritional status: weight 7.2 kg, length 74 cm, MUAC 12.3 cm, no oedema. Calculate WHZ and classify. What community-based intervention is appropriate?
  • What are the ICDS/ASHA referral criteria for malnutrition? What three anthropometric indicators should Anganwadi workers measure routinely, and what cut-offs trigger a referral?
  • The 12-year-old girl has a BMI-for-age at the 87th percentile. How do you classify her nutritional status? What lifestyle modification advice is appropriate for the family, considering the concurrent SAM risk in younger children?
  • Design three key nutrition-education messages for the Anganwadi workers' session that address both ends of the malnutrition spectrum (undernutrition and overweight) in the same community.

Group Task Assignments

Group 1: Collaborative Task

Group 2: Collaborative Task

Group 3: Collaborative Task

Learning Issues

Research these questions and bring your findings to the discussion.

  1. [PE10.1] What are the WHO/IAP criteria for classifying SAM and MAM, and what is the pathophysiological basis for distinguishing kwashiorkor from marasmus?
  2. [PE10.2] What is the clinical approach to a child with SAM in the first hour of admission? Which steps of the WHO 10-step protocol are emergency priorities?
  3. [PE10.3] How is the WHO 10-step SAM management protocol applied in practice — what specific formulae, doses, and monitoring are involved in stabilisation vs rehabilitation?
  4. [PE10.4] How do you counsel the parents of a SAM child at discharge, covering diet, danger signs, follow-up, and linkage to government nutrition programmes?
  5. [PE10.5] What is RUTF and what is its role in community-based SAM management compared to therapeutic milks (F-75/F-100) in facility-based management?
  6. [PE9.2] What tools and methods are used for nutritional assessment in children, and how are anthropometric indices (WAZ, HAZ, WHZ, MUAC) interpreted using WHO growth charts?
  7. [PE9.5] How is the daily caloric requirement calculated for children of different ages using the Holliday-Segar formula, and how does this change in disease states such as SAM?
  8. [PE9.7] How is an appropriate diet plan designed using Indian foods, and what caloric and protein density is required for catch-up growth?
  9. [PE11.1] What defines obesity in children by IAP/WHO criteria, and what are the clinical complications and management principles for childhood and adolescent obesity?
  10. [PE11.2] What are the modifiable risk factors for childhood obesity and what are the evidence-based primary prevention strategies?